251 related articles for article (PubMed ID: 18484430)
1. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
Anavekar NS; Kelly R
Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
[TBL] [Abstract][Full Text] [Related]
3. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
Browning CE; Callen JP
Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
[TBL] [Abstract][Full Text] [Related]
4. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
Davis MD; Wysokinski WE
J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
[TBL] [Abstract][Full Text] [Related]
5. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
[TBL] [Abstract][Full Text] [Related]
6. Livedoid vasculopathy and its association with factor V Leiden mutation.
Yong AA; Tan AW; Giam YC; Tang MB
Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
[TBL] [Abstract][Full Text] [Related]
7. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
Osada S; Kimura Y; Kawana S
J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
[TBL] [Abstract][Full Text] [Related]
8. [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome].
Lewerenz V; Burchardt T; Büchau A; Ruzicka T; Megahed M
Hautarzt; 2004 Apr; 55(4):379-81. PubMed ID: 15021932
[TBL] [Abstract][Full Text] [Related]
9. Livedoid vasculopathy in a patient with factor V mutation (Leiden).
Biedermann T; Flaig MJ; Sander CA
J Cutan Pathol; 2000 Sep; 27(8):410-2. PubMed ID: 10955688
[TBL] [Abstract][Full Text] [Related]
10. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
[TBL] [Abstract][Full Text] [Related]
11. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
Di Giacomo TB; Hussein TP; Souza DG; Criado PR
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1340-6. PubMed ID: 20337814
[TBL] [Abstract][Full Text] [Related]
12. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation.
Calamia KT; Balabanova M; Perniciaro C; Walsh JS
J Am Acad Dermatol; 2002 Jan; 46(1):133-7. PubMed ID: 11756961
[TBL] [Abstract][Full Text] [Related]
13. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
[TBL] [Abstract][Full Text] [Related]
14. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
[TBL] [Abstract][Full Text] [Related]
15. [Vasculitis and vasculopathy].
Marković A
Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
[TBL] [Abstract][Full Text] [Related]
16. Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
Hairston BR; Davis MD; Pittelkow MR; Ahmed I
Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831
[TBL] [Abstract][Full Text] [Related]
17. A case of livedoid vasculopathy in a 22-year-old man.
Leonard A; Pomeranz MK; Franks AG
J Drugs Dermatol; 2004; 3(6):678-9. PubMed ID: 15624752
[TBL] [Abstract][Full Text] [Related]
18. Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin.
Clivati Brandt HR; de Lorenzo Messina MC; Belda Júnior W; Costa Martins JE; Criado PR
Int J Dermatol; 2007 Dec; 46(12):1319-20. PubMed ID: 18173539
[No Abstract] [Full Text] [Related]
19. Nonhealing ulcer secondary to factor V Leiden mutation and cryofibrinogenemia.
Barrio VR; Sanfilippo AM; Malone JC; Callen JP
J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S194-6. PubMed ID: 15577768
[TBL] [Abstract][Full Text] [Related]
20. Livedoid vasculopathy; favorable clinical response with low dose warfarin.
Nakamura S; Kishibe M; Nishi K; Hashimoto Y; Takeda K; Mizumoto T; Iizuka H
Eur J Dermatol; 2011; 21(6):1011-2. PubMed ID: 21914587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
